DoctorAdam Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: seeing what it charges before you answer any medical questions
DoctorAdam's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
A Shopify-based telehealth storefront selling compounded semaglutide and tirzepatide as injections or oral tablets, at a flat all-in monthly price that covers the physician evaluation, the medication and free shipping. It names two pharmacy partners, Olympia Pharmaceuticals in Orlando, FL and Carie Boyd Pharmaceuticals in Irving, TX, and is LegitScript certified. By its own account it holds a 4.8/5 Trustpilot score across more than 5,400 reviews and has served 100K+ patients in 44 states.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to DoctorAdam
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
DoctorAdam at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $129/mo (Injection form. Verbatim from /pages/semaglutide: 'From $129'. Page compares to Ozempic® & Wegovy®, confirming compou...)
- What's included
- Medication · Consult · Shipping
- Availability
- 44 states
- FDA status
- No FDA warning letter on record
How DoctorAdam scores
Six columns, each one computed from something DoctorAdam has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
3.0/10The figures published here are not comparable monthly cash prices for the medication — an insured copay, a per-vial rate, a membership fee or a starting-dose teaser. Capped rather than scored against the register.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
7.5/10does not name a dispensing pharmacy; shows a price before asking for health information; publishes its state list. Our verification confidence is medium.
Accessibility10%
9.0/10Publishes coverage in 44 of 50 states.
Support10%
7.0/10The price covers medication, consult, shipping.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on DoctorAdam
Last checked July 2026- Re-read the price on file across 4 dose or plan tiers
- Checked state coverage: 44 states
- Established what the monthly figure covers, and what it leaves out
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with DoctorAdam involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1DoctorAdam publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3DoctorAdam does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- 4The monthly price is recorded as covering medication, consult, shipping.
- No comparable monthly cash price for the medication is on record — either nothing is published, or what is published is a fee, an insured copay or a per-vial rate rather than a monthly cost.
- Coverage is published for 44 of 50 states.
DoctorAdam support, as documented
- Phone
- (657) 282-5349
GLP-1 medications DoctorAdam offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Injection form. Verbatim from /pages/semaglutide: 'From $129'. Page compares to Ozempic® & Wegovy®, confirming compounded. 'Includes physician evaluation, prescription, medication, and shipping.'
Injection form. Verbatim from /pages/tirzepatide-injection: 'From $229 | Get Treatment'. 'Your price includes physician evaluation, prescription, medication, and shipping.'
Oral tablet form. Verbatim from /pages/oral-semaglutide: 'From $129'. Doses 2mg–24mg; physician determines strength. 'Includes medication & prescription.'
Oral tablet form. Verbatim from /pages/tirzepatide-oral-tablet: 'From $199 | Get Treatment'. Doses 3–5–6–10–20 mg; '30 oral tablets for once-daily dosing as prescribed.'
Check the price yourself before you pay
Every figure here was read off DoctorAdam's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication, consult, shipping
- Coverage is published for 44 states
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What DoctorAdam charges
The standing price at DoctorAdam is $129/month. That sits at the affordable end of what we track.
- Compounded semaglutide — $129/month
- Compounded tirzepatide — $229/month
- Compounded semaglutide — $129/month
- Compounded tirzepatide — $199/month
Across the GLP-1 providers in our register the median standing price is about $169/month, so DoctorAdam is genuinely under the middle rather than merely advertising that it is.
HealthRX, at about $133/month, is the closest thing we track to a like-for-like alternative.
What DoctorAdam dispenses
DoctorAdam prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at DoctorAdam at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a demonstrated equal to the shot.
What we could verify
On the record: it operates in 44 states. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- the lowest standing monthly cost is what you are solving for
- injections are the thing keeping you from starting
Our read
DoctorAdam competes on price and does it without an obvious sacrifice elsewhere: $129/month, no warning letter on file, and access that is not unusually restricted.
The Bottom Line
DoctorAdam's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Before you pay DoctorAdam
Starting at $129/month. Check today's price, then book the free consultation.
Where DoctorAdam is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this DoctorAdam review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See DoctorAdam's current pricing
Plans start at $129/month. The free consultation is where you learn whether you qualify, and what it costs today.